Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2026 | One big question with Francesca Morgante: what PD advance could transform care in the next 3 years?

Francesca Morgante • 27 Jun 2026
EAN 2026
Movement Disorders Parkinson's Disease

Francesca Morgante, MD, PhD, St George’s University of London, London, United Kingdom, discusses the key advances in Parkinson’s disease (PD) that could transform care in the next three years. Prof. Morgante highlights the impact of advances in technologies, such as wearable devices to monitor symptoms and inform treatment decisions. This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Francesca Morgante

Current limits of L-DOPA therapy in PD and approaches to optimization
1:19
Current limits of L-DOPA therapy in PD and approaches to optimization
Francesca Morgante • 27 Jun 2026

Related Videos

Current limits of L-DOPA therapy in PD and approaches to optimization
1:19
Current limits of L-DOPA therapy in PD and approaches to optimization
Francesca Morgante • 27 Jun 2026
Addressing obesity to improve sleep outcomes
2:40
Addressing obesity to improve sleep outcomes
Allan Damian • 17 Jun 2026
Existing and emerging neurodegeneration biomarkers in REM sleep behavior disorder
2:02
Existing and emerging neurodegeneration biomarkers in REM sleep behavior disorder
Ambra Stefani • 15 Jun 2026
The evolving field of DBS as a treatment for movement and psychiatric disorders
2:35
The evolving field of DBS as a treatment for movement and psychiatric disorders
Subeikshanan Venkatesan • 21 Apr 2026
The content of VJNeurology is intended for healthcare professionals